Population-based health care cost estimates related to breast cancer by staging.
Nicole Mittmann(Western University), C. Earle, Matthew C. Cheung(Simon Fraser University), William K. Evans(NHS Forth Valley), Maureen Trudeau(Trillium Health Centre), Natasha B. Leighl(Princess Margaret Cancer Centre), Pierre K. Isogai(Sunnybrook Health Science Centre), Refik Saskin(Ontario Institute for Cancer Research), J. Hoch, Katie N. Dainty(St. Michael's Hospital), Ning Liu
Cited by 2
Related Papers
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2018|3.7k
Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial
|The Lancet|2014|1.8k
Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL
|Journal of Clinical Oncology|2009|1.5k
Part 4: Advanced Life Support
|Circulation|2015|1.4k